Litcius/Paper detail

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Angela Wahl, Lisa E. Gralinski, Claire Johnson, Wenbo Yao, Martina Kovářová, Kenneth H. Dinnon, Hongwei Liu, Victoria J. Madden, Halina Krzystek, Chandrav De, Kristen White, Kendra L. Gully, Alexandra Schäfer, Tanzila Zaman, Sarah R. Leist, P. Grant, Gregory R. Bluemling, Alexander A. Kolykhalov, Michael G. Natchus, Frederic B. Askin, George R. Painter, Edward P. Browne, Corbin D. Jones, Raymond J. Pickles, Ralph S. Baric, J. Víctor García

2021Nature430 citationsDOIOpen Access PDF

Topics & Concepts

In vivoLungCoronavirusVirologyViral replicationVirusMiddle East respiratory syndrome coronavirusBiologyImmunologyChemokineEndogenyRespiratory systemInterferonMedicineInflammationCoronavirus disease 2019 (COVID-19)PathologyDiseaseInternal medicineInfectious disease (medical specialty)AnatomyBiotechnologyEndocrinologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 | Litcius